Regeneron and Novartis to Develop Rheumatoid Arthritis Treatment
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 35 (Table of Contents)
Published: 3 Apr-2003
DOI: 10.3833/pdr.v2003.i35.912 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Regeneron Pharmaceuticals entered into development and commercialization agreement with Novartis for developing Regeneron’s IL-1 Trap in phase II clinical trials for treating rheumatoid arthritis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS